Literature DB >> 28264938

Delivery Innovations.

.   

Abstract

The need for innovations in care delivery is recognized by providers, payers, and patients alike. Hospitals, physicians, and other clinicians are experimenting with new models of care designed to better meet patients' needs, reduce administrative burdens, and lower costs. The Affordable Care Act placed the Medicare and Medicaid programs at the center of a national effort to experiment with delivery and payment models designed to improve care and contain costs. These public-sector efforts have often aligned with private initiatives, such as the use of reference pricing-in which an insurer will only pay for a service at the price available from the lowest-cost provider. Employers in the public and private sectors have adopted value-based insurance design, in which copayments and deductibles are calibrated to the clinical benefit obtained from different services. Patients have the most to gain-or lose-from delivery innovations. Better, more efficient care should translate into better health and lower costs, but payment models designed to encourage innovation may have the unintended effect of limiting access to care. Project HOPE—The People-to-People Health Foundation, Inc.

Entities:  

Keywords:  None

Mesh:

Year:  2017        PMID: 28264938     DOI: 10.1377/hlthaff.2017.0026

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  2 in total

1.  Response to Loughlin re: "Ambulatory-Based Bladder Outlet Procedures Offer Significant Cost Savings and Comparable 30-Day Outcomes Relative to Inpatient Surgery" by Nguyen et al.

Authors:  David-Dan Nguyen; Quoc-Dien Trinh; David F Friedlander
Journal:  J Endourol       Date:  2020-10-22       Impact factor: 2.942

2.  Ambulatory-Based Bladder Outlet Procedures Offer Significant Cost Savings and Comparable 30-Day Outcomes Relative to Inpatient Procedures.

Authors:  David-Dan Nguyen; Maya Marchese; Manuel Ozambela; Naeem Bhojani; Gezzer Ortega; Quoc-Dien Trinh; David F Friedlander
Journal:  J Endourol       Date:  2020-04-07       Impact factor: 2.942

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.